Development and Evaluation of a Culturally Sensitive Structured Diabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar

Launched by RAGAE DUGHMOSH · Apr 21, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on helping people with Type 2 Diabetes in Qatar better manage their health. The current diabetes management program available in Qatar, called DESMOND, is limited in accessibility and effectiveness. To address this, researchers are developing a new program called PARADIGM-Q, which will be more affordable and tailored to the local culture. The program will teach participants through real-life examples and group discussions, helping them learn how to make healthier choices regarding their diet, exercise, and medication management.

To participate in this study, individuals must be adults aged 18 to 65 who have been diagnosed with Type 2 Diabetes and have a recent blood sugar level (HbA1c) of 8% or higher. Participants should be fluent in Arabic or English and willing to attend group education sessions. The study will take place in two phases: first, the program will be developed and tested with a small group, and then a larger study will assess its effectiveness compared to the existing program. Overall, this trial aims to create a new standard for diabetes education that can help more people live healthier lives with diabetes in Qatar and beyond.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults aged 18 to 65 years.
• • 2. Diagnosed with Type 2 Diabetes Mellitus.
• • 3. Most recent HbA1c ≥ 8% (within the last 6 months).
• • 4. Fluent in Arabic and/or English.
• • 5. Qatari and non-Qatari participants.
• • 6. Able and willing to attend group-based education sessions.
• Exclusion Criteria:
• • 1. Diagnosed with any type of diabetes other than Type 2.
• • 2. Pregnant women.
• • 3. Presence of major diabetes complications (e.g., renal failure, severe retinopathy, blindness, stroke, heart failure, cancer).
• • 4. Physical or mental disabilities that would hinder participation in education sessions.
• • 5. Age below 18 or above 65 years.